INDUCTION OF PROSTATE APOPTOSIS BY DOXAZOSIN IN BENIGN PROSTATIC HYPERPLASIA

This publication has 29 references indexed in Scilit:

• Transforming growth factor β1 transduced mouse prostate reconstitutions: II. Induction of apoptosis by doxazosin
  The Prostate, 1997
• Human prostatic smooth muscle cells in culture: Estradiol enhances expression of smooth muscle cell-specific markers
  The Prostate, 1997
• Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasteride
  Endocrinology, 1995
• The alpha‐adrenoceptor subtype mediating the tension of human prostatic smooth muscle
  The Prostate, 1993
• Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response
  Endocrinology, 1992
• The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle
  The Prostate, 1992
• Role of alpha-adrenergic blockers in the treatment of benign prostatic hyperplasia
  The Prostate, 1990
• Etiology and disease process of benign prostatic hyperplasia
  The Prostate, 1989
• The Effect of Nafarelin Acetate, a Luteinizing-Hormone–Releasing Hormone Agonist, on Benign Prostatic Hyperplasia
  New England Journal of Medicine, 1987
• A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.
  The Journal of cell biology, 1986